human metapneumovirus and human parainfluenza infection
Showing 1 - 2 of 2
Human Metapneumovirus and Human Parainfluenza Infection Trial in United States (mRNA-1653, Placebo)
Completed
- Human Metapneumovirus and Human Parainfluenza Infection
- mRNA-1653
- Placebo
-
Birmingham, Alabama
- +18 more
Feb 2, 2023
Human Metapneumovirus and Human Parainfluenza Infection Trial in Omaha, Austin, Fort Worth (mRNA-1653, Placebo)
Completed
- Human Metapneumovirus and Human Parainfluenza Infection
- mRNA-1653
- Placebo
-
Omaha, Nebraska
- +2 more
Feb 5, 2020